Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Completed · Phase 2
Conditions studied: Metastatic Breast Cancer
In brief
To determine the objective response rate (ORR) of oral satraplatin in patients with Metastatic Breast Cancer.
Key facts
- Study ID
- NCT00265655
- Run by
- Agennix
- People needed
- 40
- Starts
- 2005-11-01
- Expected to finish
- 2008-02-01
- Last updated by the study team
- 2012-03-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- US Oncology — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.